2221-996x

Biological Products Prevention Diagnosis Treatment

SCEEMP

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 41 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact41 DOIs
2

Add abstracts to 38 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact38 DOIs
3

Deposit reference lists for 35 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact35 DOIs

DOIs for this ISSN

Showing the top 5 of 251 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 The Current Use of Biomedical Cell Products for Cancer Treat… (10.30895/2221-996x-2019-19-4-206-214)
Abstract
15.05 3
2 Study of biological properties of <I>Leptospira interr… (10.30895/2221-996x-2021-21-1-64-69)
ORCID
11.93 2
3 Optimisation of the Microbial Cell Concentration Procedure i… (10.30895/2221-996x-2019-19-1-50-55)
ORCID
7.53 1
4 Specific Aspects of Tuberculin Products Standardisation (10.30895/2221-996x-2019-19-1-56-63)
Abstract
7.53 1
5 Comparative analysis of quality attributes of a human albumi… (10.30895/2221-996x-2023-23-3-1-411-421)
ORCID
7.53 1
6 Determination of Viral Nucleic Acid in the Human Blood (10.30895/2221-996x-2018-18-4-208-215)
0.00 0
7 International Practice of Storing Human Cell Lines Intended… (10.30895/2221-996x-2018-18-4-216-224)
0.00 0
8 Retrospective Analysis of Viral Hepatitis B Incidence in Rus… (10.30895/2221-996x-2018-18-4-225-235)
0.00 4
9 Preventive Vaccination against Poliomyelitis: Modern View (10.30895/2221-996x-2018-18-4-236-242)
0.00 1
10 Estimation of Consistency of Production of the Pertussis Com… (10.30895/2221-996x-2018-18-4-243-248)
0.00 3
11 Using Real-Time RT-PCR Reagent Kits for Identity Testing of… (10.30895/2221-996x-2018-18-4-249-256)
0.00 1
12 Certification of a New Batch of the Industry Reference Stand… (10.30895/2221-996x-2018-18-4-257-261)
0.00 0
13 Certification of a New Batch of the Industry Reference Stand… (10.30895/2221-996x-2018-18-4-262-267)
0.00 1
14 Current Challenges of Preventive Vaccination Against Rabies (10.30895/2221-996x-2019-19-1-10-16)
0.00 13
15 Authorisation of Non-Innovator Biotherapeutic (Biosimilar) P… (10.30895/2221-996x-2019-19-1-17-27)
0.00 0
16 Justification of Methodological Approaches to Identification… (10.30895/2221-996x-2019-19-1-28-38)
0.00 5
17 Physico-Chemical and Biological Properties of Biosimilar and… (10.30895/2221-996x-2019-19-1-39-49)
0.00 10
18 Development of an Approach to the Assessment of Changes to A… (10.30895/2221-996x-2019-19-2-109-117)
0.00 2
19 Evaluation of the Stability of Performance of the Analytical… (10.30895/2221-996x-2019-19-2-118-123)
0.00 1
20 DNA and RNA Vaccines: Current Status, Quality Requirements a… (10.30895/2221-996x-2019-19-2-72-80)
0.00 7
21 Rotavirus Epidemiology and Vaccination Tactics (10.30895/2221-996x-2019-19-2-81-87)
0.00 5
22 Metal Allergy (10.30895/2221-996x-2019-19-2-88-93)
0.00 3
23 Biomedical Cell Products or High-Tech Drugs? (10.30895/2221-996x-2019-19-2-94-98)
0.00 2
24 Comparative Analysis of Russian and Foreign Pharmacopoeial R… (10.30895/2221-996x-2019-19-2-99-108)
0.00 2
25 Culture Media in Pharmacopoeial Analysis: Use, Current Requi… (10.30895/2221-996x-2019-19-3-136-144)
0.00 3
26 Special Considerations on the Use of Vaccines for Immunoprop… (10.30895/2221-996x-2019-19-3-145-153)
0.00 1
27 Analysis of Measles Incidence in Russia and Problems of Meas… (10.30895/2221-996x-2019-19-3-154-160)
0.00 15
28 Ways to Improve Quality Control of Culture Medium Used for M… (10.30895/2221-996x-2019-19-3-161-168)
0.00 3
29 Pharmacokinetics of Recombinant Human Tumor Necrosis Factor… (10.30895/2221-996x-2019-19-3-169-177)
0.00 0
30 Diagnosis of Latent Tuberculosis Infection in Personnel of V… (10.30895/2221-996x-2019-19-3-178-184)
0.00 3
31 Development and Certification of Calcium Chloride Casein Ref… (10.30895/2221-996x-2019-19-3-185-192)
0.00 0
32 Vaccine Safety and Efficacy in Preventing Rotavirus Infectio… (10.30895/2221-996x-2019-19-4-215-224)
0.00 1
33 Treatment of Genetic Diseases: Current Trends in the Develop… (10.30895/2221-996x-2019-19-4-225-232)
0.00 3
34 Elaboration of Pharmacopoeial Quality Standards for Bacterio… (10.30895/2221-996x-2019-19-4-233-241)
0.00 0
35 Development of a Mouse Glioblastoma Orthotopic Model Using t… (10.30895/2221-996x-2019-19-4-242-250)
0.00 0
36 The Use of Short Tandem Repeat Analysis for Cell Line Authen… (10.30895/2221-996x-2019-19-4-251-260)
0.00 4
37 Experimental Testing of a Size-Exclusion Chromatography Meth… (10.30895/2221-996x-2019-19-4-261-267)
0.00 1
38 Immune Response Induced by Immunisation with Antiviral Vacci… (10.30895/2221-996x-2020-20-1-21-29)
0.00 8
39 General Considerations on Clinical Trials of Hemophilia Medi… (10.30895/2221-996x-2020-20-1-30-41)
0.00 1
40 Internalization of Recombinant Imiglucerase into Mouse Perit… (10.30895/2221-996x-2020-20-1-42-49)
0.00 0
41 Properties of Heterologous anti-Ebola Immunoglobulin after L… (10.30895/2221-996x-2020-20-1-50-59)
0.00 1
42 An Outbreak of a New Infectious Disease COVID-19: β-coronavi… (10.30895/2221-996x-2020-20-1-6-20)
0.00 23
43 Protecting Mice from H7 Avian Influenza Virus by Immunisatio… (10.30895/2221-996x-2020-20-1-60-67)
0.00 2
44 Aspects of a Methodological Approach to Determination of Int… (10.30895/2221-996x-2020-20-1-68-73)
0.00 0
45 Madariaga Virus (10.30895/2221-996x-2020-20-2-103-106)
0.00 0
46 Molecular Genetic Testing of Stability and Identification of… (10.30895/2221-996x-2020-20-2-107-115)
0.00 2
47 Characterisation of Recombinant Human Erythropoietin Obtaine… (10.30895/2221-996x-2020-20-2-116-125)
ORCID
0.00 0
48 Prospects for Improving Quality Evaluation of the Live Bruce… (10.30895/2221-996x-2020-20-2-126-135)
0.00 2
49 Current Trends in the Use of Cell Therapy in Regenerative Me… (10.30895/2221-996x-2020-20-2-82-88)
0.00 1
50 Bioethical Aspects of Improving the Production of Rabies Imm… (10.30895/2221-996x-2020-20-2-89-96)
0.00 2